These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11992302

  • 1. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation.
    Muretto P, Angelucci E, Lucarelli G.
    Ann Intern Med; 2002 May 07; 136(9):667-72. PubMed ID: 11992302
    [Abstract] [Full Text] [Related]

  • 2. Summaries for patients. Reversibility of liver scarring in patients who are cured of thalassemia.
    Ann Intern Med; 2002 May 07; 136(9):I36. PubMed ID: 11992322
    [No Abstract] [Full Text] [Related]

  • 3. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
    Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B, Galimberti M, Giardini C, Gaziev D, Polchi P.
    Blood; 1997 Aug 01; 90(3):994-8. PubMed ID: 9242528
    [Abstract] [Full Text] [Related]

  • 4. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.
    Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, Ripalti M, Sodani P, Tomassoni S, Visani G, Lucarelli G.
    Blood; 2002 Jul 01; 100(1):17-21. PubMed ID: 12070002
    [Abstract] [Full Text] [Related]

  • 5. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
    Wu SF, Peng CT, Wu KH, Tsai CH.
    Hemoglobin; 2006 Jul 01; 30(2):215-8. PubMed ID: 16798646
    [Abstract] [Full Text] [Related]

  • 6. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
    Chen AC, Peng CT, Wu SF, Wu KH, Chiang IP, Tsai CH.
    Hemoglobin; 2006 Jul 01; 30(2):209-14. PubMed ID: 16798645
    [Abstract] [Full Text] [Related]

  • 7. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation.
    Meo A, Ruggeri A, La Rosa MA, Zanghì L, Morabito N, Duca L.
    Hemoglobin; 2006 Jul 01; 30(1):131-7. PubMed ID: 16540426
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G.
    Ann N Y Acad Sci; 2005 Jul 01; 1054():196-205. PubMed ID: 16339666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Liver iron stores before and after bone marrow transplantation for thalassemia.
    Politi P, Lucarelli G, Capriotti L, Salvadori P, Dardanelli C, Barbanti I.
    Prog Clin Biol Res; 1989 Jul 01; 309():281-9. PubMed ID: 2675096
    [No Abstract] [Full Text] [Related]

  • 11. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia.
    Giardini C, Galimberti M, Lucarelli G, Polchi P, Angelucci E, Baronciani D, Gaziev D, Erer B, La Nasa G, Barbanti I.
    Br J Haematol; 1995 Apr 01; 89(4):868-73. PubMed ID: 7772524
    [Abstract] [Full Text] [Related]

  • 12. Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.
    Deugnier Y, Turlin B, Ropert M, Cappellini MD, Porter JB, Giannone V, Zhang Y, Griffel L, Brissot P.
    Gastroenterology; 2011 Oct 01; 141(4):1202-11, 1211.e1-3. PubMed ID: 21741344
    [Abstract] [Full Text] [Related]

  • 13. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E, Baronciani D, Lucarelli G, Giardini C, Galimberti M, Polchi P, Martinelli F, Baldassarri M, Muretto P.
    Bone Marrow Transplant; 1993 Oct 01; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract] [Full Text] [Related]

  • 14. A prospective evaluation of iron chelation therapy in children with severe beta-thalassemia. A six-year study.
    Maurer HS, Lloyd-Still JD, Ingrisano C, Gonzalez-Crussi F, Honig GR.
    Am J Dis Child; 1988 Mar 01; 142(3):287-92. PubMed ID: 3344715
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.
    Gumus E, Abbasoglu O, Tanyel C, Gumruk F, Ozen H, Yuce A.
    Pediatr Transplant; 2017 May 01; 21(3):. PubMed ID: 28211259
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hepatitis C virus infection in thalassemia.
    Butensky E, Pakbaz Z, Foote D, Walters MC, Vichinsky EP, Harmatz P.
    Ann N Y Acad Sci; 2005 May 01; 1054():290-9. PubMed ID: 16339677
    [Abstract] [Full Text] [Related]

  • 17. Hepatic iron concentration and total body iron stores in thalassemia major.
    Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G.
    N Engl J Med; 2000 Aug 03; 343(5):327-31. PubMed ID: 10922422
    [Abstract] [Full Text] [Related]

  • 18. Incidence of hepatocellular carcinoma in a thalassemia unit.
    Fragatou S, Tsourveloudis I, Manesis G.
    Hemoglobin; 2010 Jun 03; 34(3):221-6. PubMed ID: 20524812
    [Abstract] [Full Text] [Related]

  • 19. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Maira D, Cassinerio E, Marcon A, Mancarella M, Fraquelli M, Pedrotti P, Cappellini MD.
    Ann Hematol; 2017 Nov 03; 96(11):1931-1936. PubMed ID: 28875336
    [Abstract] [Full Text] [Related]

  • 20. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P, Giua R, De Marco S, Bonetti MG, Amurri B, Masi C, Lazzari G, Rizzo C, Cervellera M, Peluso A.
    Haematologica; 1995 Nov 03; 80(5):398-404. PubMed ID: 8566878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.